Association between Cystatin C and arteriosclerosis in the absence of chronic kidney disease

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 6, 2013, Pages 548-556

  Yamashita, Hiroshi ^a   Nishino, Tomoya ^a   Obata, Yoko ^a,b   Nakazato, Mio ^c   Inoue, Keita ^c   Furusu, Akira ^a   Takamura, Noboru ^c   Maeda, Takahiro ^c   Ozono, Yoshiyuki ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Cardio ankle vascular index (CAVI); Cardiovascular disease; Carotid intima media thickness (CIMT); Cystatin C

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; BODY MASS; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; SYSTOLIC BLOOD PRESSURE; TURBIDIMETRY; WAIST CIRCUMFERENCE;

ADULT; AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; VASCULAR STIFFNESS;

EID: 84879493955     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13193     Document Type: Article

References (46)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA, 2007; 298: 2038-2047
2. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol, 2009; 13: 621-630
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169
4. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H: The burden of kidney disease: improving global outcomes. Kidney Int, 2004; 66: 1310-1314
5. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002; 39: S1-S266
6. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality. J Am Soc Nephrol, 2004; 15: 1307-1315
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305
8. Simonsen O, Grubb A, Thysell H: The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration. Scand J Clin Lab Invest, 1985; 45: 97-101
9. Shlipak MG, Praught ML, Sarnak MJ: Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens, 2006; 15: 270-275
10. Grubb AO: Cystatin C-properties and use as diagnostic marker. Adv Clin Chem, 2000; 35: 63-99
11. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1997; 47: 312-318
12. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotidnintima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation, 1997; 96: 1432-1437
13. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G: Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults (The Atherosclerosis Risk in Communities (ARIC) Study). Stroke, 1995; 26: 386-391
14. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (Cardiovascular Health Study Collaborative Research Group). N Engl J Med, 1999; 340: 14-22
15. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M: Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke, 2006; 37: 87-92
16. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res, 2002; 25: 359-364
17. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
18. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, Nitta S, Kuwayama T: Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother, 2004; 58: S95-S98
19. Kubozono T, Miyata M, Ueyama K, Nagaki A, Hamasaki S, Kusano K, Kubozono O, Tei C: Association between arterial stiffness and estimated glomerular filtration rate in the Japanese general population. J Atheroscler Thromb, 2009; 16: 840-845
20. Han L, Bai X, Lin H, Sun X, Chen XM: Lack of independent relationship between age-related kidney function decline and carotid intima-media thickness in a healthy Chinese population. Nephrol Dial Transplant, 2010; 25: 1859-1865
21. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: CAVI is a Candidate Predictor of Coronary Atherosclerosis. Circ J, 2008; 72: 598-604
22. Bui AL, Katz R, Kestenbaum B, de Boer IH, Fried LF, Polak JF, Wasserman BA, Sarnak MJ, Siscovick D, Shlipak MG: Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis, 2009; 53: 389-398
23. Rodondi N, Yerly P, Gabriel A, Riesen WF, Burnier M, Paccaud F, Bovet P: Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middleaged adults. Nephrol Dial Transplant, 2007; 22: 11071114
24. Skalska A, Klimek E, Wizner B, Gasowski J, Grodzicki T: Kidney function and thickness of carotid intima-media complex in patients with treated arterial hypertension. Blood Press, 2007; 16: 367-374
25. Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N: An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med, 2008; 47: 391-398
26. Watanabe S, Okura T, Liu J, Miyoshi K, Fukuoka T, Hiwada K, Higaki J: Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res, 2003; 26: 895-899
27. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M; Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis: Diagnostic criteria for dyslipidemia. Executive summary of Japan AtherosclerosisSociety (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb, 2007; 14: 155-158
28. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res, 2009; 32: 3-107
29. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H: Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation, 2012; 3: 39-40
30. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Collaborators developing the Japanese equation for estimated GFR: Revised Equations for Estimated GFR From Serum Creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992
31. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis, 2000; 36: 29-34
32. Hoek FJ, Kemperman FA, Krediet RT: A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant, 2003; 18: 2024-2031
33. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis, 2002; 40: 221-226
34. Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE; PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int, 2005; 67: 1967-1973
35. Izuhara M, Shioji K, Kadota S, Baba O, Takeuchi Y, Uegaito T, Mutsuo S, Matsuda M: Relationship of cardioankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J, 2008; 72: 1762-1767
36. Rokadia HK, Agarwal S: Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES). Lung, 2012; 190: 283-290
37. Odden MC, Tager IB, Gansevoort RT, Bakker SJ, Katz R, Fried LF, Newman AB, Canada RB, Harris T, Sarnak MJ, Siscovick D, Shlipak MG: Age and cystatin C in healthy adults: a collaborative study. Nephrol Dial Transplant, 2010; 25: 463-469
38. Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J: Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis, 2008; 51: 385-394
39. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int, 2004; 65: 1416-1421
40. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int, 2009; 75: 652-660, 2009
41. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis, 2000; 36: 29-34
42. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med, 1998; 339: 1448-1456
43. Chan DT, Irish AB, Dogra GK, Watts GF: Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis, 2008; 196: 823-834
44. Wright J, Hutchison A: Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag, 2009; 5: 713-722
45. Rosenson RS: Low HDL-C: a secondary target of dyslipidemia therapy. Am J Med, 2005; 118: 1067
46. Zhang Z, Lu B, Sheng X, Jin N: Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis, 2011; 58: 356-365